Protuoso Biosciences
PrivateLast Round
Seed
May 27, 2026
Total Funding Raised
$9.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Protuoso Biosciences operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Seed round in May 2026.
Protuoso Biosciences is a biotechnology company that develops a protein synthetic biology platform to create multifunctional biologics for complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protuoso Biosciences Comparables
Compare Protuoso Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evozyne | 77% | |
| LabGenius Therapeutics | 77% | |
| BigHat Biosciences | 77% |
For institutional investors. Book with your work email.
Protuoso Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Protuoso Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Darwin Venture Management | Seed |
| NSG Ventures | Seed |
| Darwin Ventures | Seed |
| SEEDS Capital | Seed |
| Darwin Ventures | Seed |
| TA YA VENTURE HOLDINGS LIMITED | Seed |
| SEEDS Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$9.5M round led by Taya Ventures and Darwin Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 14, 2026
Protuoso is developing modular biologics that target multi-pathway diseases using synthetic biology engineering, computational protein design, and AI-based screening to address complex diseases in a synergistic and scalable format in Aug '26.
For institutional investors. Book with your work email.
Protuoso Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Protuoso Biosciences's valuation, stock price, and market status.
Is Protuoso Biosciences a public or private company?
Protuoso Biosciences is a private company.
What is the current stock price of Protuoso Biosciences?
Protuoso Biosciences is a private company, so its shares have no public market price. Caplight tracks Protuoso Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Protuoso Biosciences worth (valuation)?
Valuation information for Protuoso Biosciences is not publicly available.
Can I buy Protuoso Biosciences stock?
Protuoso Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Protuoso Biosciences's last funding round?
Protuoso Biosciences's most recent funding round was Seed on May 27, 2026.
Who are the main investors in Protuoso Biosciences?
Key investors in Protuoso Biosciences include Darwin Venture Management, Darwin Ventures, Darwin Ventures, TA YA VENTURE HOLDINGS LIMITED, Taya Ventures.
Will Protuoso Biosciences IPO soon?
No public IPO plans have been announced for Protuoso Biosciences.
How can I track Protuoso Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Protuoso Biosciences's shares on secondary markets.